VALLEY NATIONAL ADVISERS INC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 773411
BETHLEHEM, PA
Position in BCRX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$100
New position
Shares Held
10
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#313
of 316 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $94,449 across 13 Drug Manufacturers - Specialty & Generic names. BCRX ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHC |
Bausch Health Companies Inc.
|
8,553 | $42,166 | |
| 2 | ZTS |
Zoetis Inc.
|
200 | $14,372 | |
| 3 | VTRS |
Viatris Inc
|
617 | $9,797 | |
| 4 | HLN |
Haleon plc
|
1,017 | $9,488 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
62 | $6,878 | |
| 6 | CRDL |
Cardiol Therapeutics Inc.
|
5,000 | $5,300 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
6 | $3,250 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
85 | $2,879 |
All Filings in BCRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100 | 10 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||